Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia

Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia

This is a multicenter cohort study including consecutive, hospitalized patients ≥18 years, with moderate to severe COVID-19, carried out to evaluate the relationship between the timing of convalescent plasma administration and 28-day mortality. Data were prospectively collected between May 14, 2020...

Full description

Bibliographic Details
Main Authors: Carrera Ramos, P.M (Author), Estenssoro, E. (Author), Ferrando, N.S (Author), González Martínez, V.V (Author), González, S.E (Author), Kreplak, N. (Author), Pesci, S.A (Author), Regairaz, L. (Author), Salazar, M.R (Author), Vidal, J.M (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
clinical trial
cohort analysis
Cohort Studies
COVID-19
human
Humans
Immunization, Passive
multicenter study
passive immunization
pneumonia
SARS-CoV-2
therapy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items